Biosimilar Deals Updates: Biocon, AstraZeneca

Start
As an update to our previous report, Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.) announced the successful completion of the transition of the acquired biosimilars business in approximately 120 countries, a year ahead of schedule….
By: Goodwin
Previous Story

CRISPR Regulatory Updates

Next Story

Cardiothoracic and Vascular Surgeons Files Notice of Data Breach Affecting an Unknown Number of Patient SSNs